# Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal Markers

> **NCT03469518** · NA · UNKNOWN · sponsor: **Puerta de Hierro University Hospital** · enrollment: 40 (actual)

## Conditions studied

- Hypercholesterolemia
- Osteoporosis
- Postmenopausal Disorder

## Interventions

- **DIETARY_SUPPLEMENT:** β-Cx plus PS plus GOS
- **DIETARY_SUPPLEMENT:** β-Cx plus PS

## Key facts

- **NCT ID:** NCT03469518
- **Lead sponsor:** Puerta de Hierro University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-01
- **Primary completion:** 2017-07
- **Final completion:** 2019-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-05-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03469518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03469518, "Effect of β-cryptoxanthin (β-Cx), Plant Sterols and Galactooligosaccharides on Systemic and Gastrointestinal Markers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03469518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*